Showing results (41-50 of 57) with videos related to
Sort By:
Pageof 6
BMC Rheumatology|February 27, 2020
The effect of glucocorticoid therapy on mortality in patients with rheumatoid arthritis and concomitant type II diabetes: a retrospective cohort studyRuth E Costello, Antonia Marsden, Mohammad Movahedi, et al.Clinical and Experimental Rheumatology|November 18, 2017
Treatment patterns in rheumatoid arthritis after discontinuation of methotrexate: data from the Ontario Best Practices Research Initiative (OBRI)Janet E Pope, Emmanouil Rampakakis, Mohammad Movahedi, et al.RMD Open|November 30, 2018
ACPA and RF as predictors of sustained clinical remission in patients with rheumatoid arthritis: data from the Ontario Best practices Research Initiative (OBRI)Janet E Pope, Mohammad Movahedi, Emmanouil Rampakakis, et al.Current Rheumatology Reviews|December 14, 2020
Changes in Market Share of Biologic and Targeted Synthetic Disease-Modifying Anti-Rheumatic Drugs for Treatment of Rheumatoid Arthritis: Results from the Ontario Best-Practice Research Initiative DatabaseElliot Hepworth, Mohammad Movahedi, Emmanouil Rampakakis, et al.The Journal of Rheumatology|July 3, 2019
Toward Defining Primary and Secondary Nonresponse in Rheumatoid Arthritis Patients Treated with Anti-TNF: Results from the BioTRAC and OBRI RegistriesEdward C Keystone, Emmanouil Rampakakis, Mohammad Movahedi, et al.The Journal of Rheumatology|April 17, 2019
Effect of Concomitant Disease-modifying Antirheumatic Drugs and Methotrexate Administration Route on Biologic Treatment Durability in Rheumatoid Arthritis: OBRI Cohort ResultsArthur N Lau, J Carter Thorne, Mohammad Movahedi, et al.Rheumatology (Oxford, England)|June 23, 2026
Persistence and Effectiveness of upadacitinib and TNFi for rheumatoid arthritis using pooled data from Canadian and Swiss registriesDenis Choquette, Axel Finckh, Andrea Rubbert-Roth, et al.ACR Open Rheumatology|September 30, 2024
Evaluation of Progression From Preclinical to Systemic Autoimmune Rheumatic Disease: Novel Use of the European Alliance of Associations for Rheumatology/American College of Rheumatology Systemic Lupus Erythematosus Classification Criteria as an Outcome MeasureSindhu R Johnson, Hana Alahmari, Dennisse Bonilla, et al.The Canadian Journal of Cardiology|April 16, 2022
Statin Use for Primary Cardiovascular Disease Prevention Is Low in Inflammatory ArthritisBindee Kuriya, Shadi Akhtari, Mohammad Movahedi, et al.Rheumatology Advances in Practice|May 14, 2023
Impact of the COVID-19 pandemic on patients with rheumatoid arthritis: data from the Ontario Best Practices Research Initiative (OBRI)Matthew Wong-Pack, Elliot Hepworth, Mohammad Movahedi, et al.Pageof 6